SCHEMBL12670545

SCHEMBL12670545

CCO[C@H](COc1ccc(C)cc1)CSc1ccc(OCC(=O)O)c(C)c1

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.80
PPARA Q07869 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377508 0.92 PPARD (0.78) PPARDPPARA
SCHEMBL377469 0.92 PPARD (0.78) PPARDPPARA
SCHEMBL13680160 0.92 PPARD (0.81) PPARDPPARA
SCHEMBL377637 0.90 PPARD (0.84) PPARDPPARA
SCHEMBL377636 0.90 PPARD (0.84) PPARDPPARA
Seladelpar SCHEMBL390098 0.89 PPARD (1.00) PPARDPPARA
Seladelpar SCHEMBL394392 0.89 PPARD (1.00) PPARDPPARA
Seladelpar SCHEMBL29373526 0.89 PPARD (1.00) PPARDPPARA
Seladelpar SCHEMBL392331 0.89 PPARD (1.00) PPARDPPARA
SCHEMBL377627 0.89 PPARD (0.83) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669288-B2 Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2014-03-11 US disclosed
US-20110105616-A1 NOVEL LYSINE SALTS OF 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACID DERIVATIVES CYMABAY THERAPEUTICS, INC. 2011-05-05 US disclosed
US-20070060649-A1 NOVEL LYSINE SALTS OF 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACID DERIVATIVES CYMABAY THERAPEUTICS, INC. 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060649-A1 NOVEL LYSINE SALTS OF 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACID DERIVATIVES PPARA, PPARD, PPARG PPARD 2/4885PPARA 1/4885
US-20110105616-A1 NOVEL LYSINE SALTS OF 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACID DERIVATIVES PPARA, PPARD, PPARG PPARD 2/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.